3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
3
Genitourinary
3
Sarcoma
2
Myeloid
2
Head & Neck
2
Gastrointestinal
2
Breast
2
Plasma cell
1
Other solid neoplasm
1
Other neoplasm
1
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Gynecologic
1
Endocrine
1
Dermatologic
1
Classical hematology
1
CNS
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
lutetium Lu 177 dotatate
6
Magnetic Resonance Spectroscopy
3
Data Collection
3
telotristat ethyl
2
surufatinib
2
Somatostatin
2
Positron-Emission Tomography
2
Everolimus
2
Drug Therapy
2
Biopsy
2
lanreotide
1
copper dotatate CU-64
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sunitinib
1
Sorafenib
1
Salvage Therapy
1
Radionuclide Imaging
1
Radiomics
1
Radiofrequency Ablation
1
Quality of Life
1
Plastic Surgery Procedures
1
Phlebotomy
1
Patient Reported Outcome Measures
1
Octreotide
1
Molecular Diagnostic Techniques
1
Lutetium-177
1
Lutetium
1
Liver Transplantation
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Molecular Diagnostic Techniques
×
NET
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled